ANTISYNTHETASE SYNDROME

Clinical trials for ANTISYNTHETASE SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ANTISYNTHETASE SYNDROME trials appear

Sign up with your email to follow new studies for ANTISYNTHETASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New study tests safer, more effective First-Line therapy for rare lung disease

Disease control Not yet recruiting

This study compares two types of drugs—JAK inhibitors and calcineurin inhibitors—as the first treatment for lung scarring (interstitial lung disease) caused by antisynthetase syndrome, a rare autoimmune condition. About 80 adults aged 18 to 75 who have not yet taken immune-suppre…

Matched conditions: ANTISYNTHETASE SYNDROME

Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control

Last updated May 15, 2026 12:01 UTC

ANTISYNTHETASE SYNDROME

Get alerted when new ANTISYNTHETASE SYNDROME trials appear

New study tests safer, more effective First-Line therapy for rare lung disease